MY155646A - Pharmaceutical preparation - Google Patents
Pharmaceutical preparationInfo
- Publication number
- MY155646A MY155646A MYPI2011005080A MYPI2011005080A MY155646A MY 155646 A MY155646 A MY 155646A MY PI2011005080 A MYPI2011005080 A MY PI2011005080A MY PI2011005080 A MYPI2011005080 A MY PI2011005080A MY 155646 A MY155646 A MY 155646A
- Authority
- MY
- Malaysia
- Prior art keywords
- pharmaceutical preparation
- compositions
- buccal
- spray
- treatment
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- BJDCWCLMFKKGEE-HVDUHBCDSA-N Dihydroartemesinin Chemical group C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(O)[C@@H]4C BJDCWCLMFKKGEE-HVDUHBCDSA-N 0.000 abstract 1
- 206010061217 Infestation Diseases 0.000 abstract 1
- 208000016604 Lyme disease Diseases 0.000 abstract 1
- 241000935974 Paralichthys dentatus Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2009/050415 WO2010122275A1 (en) | 2009-04-23 | 2009-04-23 | Pharmaceutical preparation |
| GB0906971.7A GB2469791B (en) | 2009-04-23 | 2009-04-23 | Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY155646A true MY155646A (en) | 2015-11-13 |
Family
ID=42244197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011005080A MY155646A (en) | 2009-04-23 | 2010-04-23 | Pharmaceutical preparation |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20120157518A1 (https=) |
| EP (1) | EP2424523B1 (https=) |
| JP (1) | JP5795760B2 (https=) |
| CN (1) | CN102395362B (https=) |
| AU (1) | AU2010240654C1 (https=) |
| BR (1) | BRPI1014887A8 (https=) |
| CA (1) | CA2756925A1 (https=) |
| DK (1) | DK2424523T3 (https=) |
| ES (1) | ES2390046T3 (https=) |
| HR (1) | HRP20120711T1 (https=) |
| IL (1) | IL215453A (https=) |
| ME (1) | ME02008B (https=) |
| MX (1) | MX2011010961A (https=) |
| MY (1) | MY155646A (https=) |
| NZ (1) | NZ595469A (https=) |
| PL (1) | PL2424523T3 (https=) |
| PT (1) | PT2424523E (https=) |
| RS (1) | RS52430B (https=) |
| RU (1) | RU2501550C2 (https=) |
| SG (1) | SG175162A1 (https=) |
| SI (1) | SI2424523T1 (https=) |
| WO (1) | WO2010122356A1 (https=) |
| ZA (1) | ZA201107088B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| SG175160A1 (en) * | 2009-04-23 | 2011-11-28 | Londonpharma Ltd | Sublingual pharmaceutical composition comprising a neutral oil |
| JP6513576B2 (ja) * | 2013-01-14 | 2019-05-15 | ヘルス クリニックス リミテッド | 抗がん剤および使用 |
| US20170326102A1 (en) | 2014-11-27 | 2017-11-16 | Cipla Limited | Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery |
| JP2020033304A (ja) * | 2018-08-30 | 2020-03-05 | 医療法人ふじいやさか | 薬剤又はサプリメント、組成物、及び水素供給器の使用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| CH692321A5 (de) * | 1997-11-03 | 2002-05-15 | Mepha Ag | Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält. |
| KR100640113B1 (ko) * | 1998-07-14 | 2006-10-31 | 바이엘 악티엔게젤샤프트 | 구충제 아르테미시닌 유도체(엔도퍼옥시드) |
| WO2002053138A2 (en) * | 2001-01-02 | 2002-07-11 | Elisabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| MXPA04011808A (es) * | 2002-05-31 | 2005-09-12 | Univ Mississippi | Liberacion transmucosica de canabinoides. |
| CA2488347A1 (en) * | 2002-06-06 | 2003-12-18 | University Of Washington | Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| WO2004075921A1 (en) * | 2003-02-26 | 2004-09-10 | Vrije Universiteit Brussel | Inclusion complex of artemisinin or derivates thereof with cyclodextrins |
| US20060084675A1 (en) * | 2004-10-18 | 2006-04-20 | Thomas Efferth | Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor |
| US20060233895A1 (en) * | 2005-04-15 | 2006-10-19 | Brown Paul R | Herbal remedy for treating Lyme disease |
| WO2007043057A2 (en) * | 2005-10-11 | 2007-04-19 | Yissum, Research Development Company Of The Hebrew University Of Jerusalem | Compositions for nasal delivery |
| CN100418524C (zh) * | 2005-10-26 | 2008-09-17 | 重庆医药工业研究院有限责任公司 | 一种稳定的青蒿素及青蒿素衍生物的药物组合物 |
-
2010
- 2010-04-23 SI SI201030076T patent/SI2424523T1/sl unknown
- 2010-04-23 PL PL10715337T patent/PL2424523T3/pl unknown
- 2010-04-23 MY MYPI2011005080A patent/MY155646A/en unknown
- 2010-04-23 RU RU2011139637/15A patent/RU2501550C2/ru active
- 2010-04-23 ME MEP-2012-393A patent/ME02008B/me unknown
- 2010-04-23 SG SG2011073954A patent/SG175162A1/en unknown
- 2010-04-23 BR BRPI1014887A patent/BRPI1014887A8/pt not_active Application Discontinuation
- 2010-04-23 NZ NZ595469A patent/NZ595469A/xx not_active IP Right Cessation
- 2010-04-23 CA CA2756925A patent/CA2756925A1/en not_active Abandoned
- 2010-04-23 CN CN201080017965.1A patent/CN102395362B/zh not_active Expired - Fee Related
- 2010-04-23 PT PT10715337T patent/PT2424523E/pt unknown
- 2010-04-23 RS RS20120393A patent/RS52430B/sr unknown
- 2010-04-23 DK DK10715337.1T patent/DK2424523T3/da active
- 2010-04-23 ES ES10715337T patent/ES2390046T3/es active Active
- 2010-04-23 EP EP10715337A patent/EP2424523B1/en active Active
- 2010-04-23 US US13/265,518 patent/US20120157518A1/en not_active Abandoned
- 2010-04-23 MX MX2011010961A patent/MX2011010961A/es active IP Right Grant
- 2010-04-23 AU AU2010240654A patent/AU2010240654C1/en not_active Ceased
- 2010-04-23 WO PCT/GB2010/050672 patent/WO2010122356A1/en not_active Ceased
- 2010-04-23 HR HRP20120711AT patent/HRP20120711T1/hr unknown
- 2010-04-23 JP JP2012506584A patent/JP5795760B2/ja not_active Expired - Fee Related
-
2011
- 2011-09-28 ZA ZA2011/07088A patent/ZA201107088B/en unknown
- 2011-10-02 IL IL215453A patent/IL215453A/en active IP Right Grant
-
2015
- 2015-07-30 US US14/813,424 patent/US20160022629A1/en not_active Abandoned
-
2017
- 2017-09-06 US US15/697,240 patent/US20170368023A1/en not_active Abandoned
-
2018
- 2018-10-18 US US16/164,610 patent/US20190142737A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02805A (https=) | ||
| EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
| PH12013501567A1 (en) | Anti-malarial pharmaceutical composition | |
| PH12012502161A1 (en) | Pharmaceutical formulations comprising pioglitazone and linagliptin | |
| MY140826A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments. | |
| MA32200B1 (fr) | Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation | |
| PH12013501842A1 (en) | Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor | |
| MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
| UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
| MY151048A (en) | Use of flibanserin for the treatment of post-menopausal sexual desire disorders | |
| MX2011011776A (es) | Nuevos profarmacos de triptolite. | |
| WO2007048801A3 (en) | Sexual desire enhancing medicaments comprising benzimidazolone derivatives | |
| CR20120084A (es) | Composiciones farmacéuticas para el tratamiento del cáncer y otras enfermedades o trastornos | |
| TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| WO2010089327A3 (en) | Indole derivatives as anticancer agents | |
| MY155646A (en) | Pharmaceutical preparation | |
| UA97401C2 (ru) | Экструдат с улучшенной маскировкой вкуса | |
| WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
| EA201200485A1 (ru) | Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол | |
| TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MX367327B (es) | Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos. | |
| WO2010122275A8 (en) | Pharmaceutical preparation | |
| TW200745042A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MX2008013477A (es) | Compuestos biciclicos de tetrahidropirrol. | |
| WO2010139411A3 (de) | 17β-ALKYL-17α-OXY-ESTRATRIENE |